Literature DB >> 21531002

Chromosome aberrations associated with centrosome defects: a study of comparative genomic hybridization in breast cancer.

Yuxia Gao1, Yun Niu, Xiaowei Wang, Li Wei, Rongju Zhang, Shuhua Lv, Qi Yu, Xue Yang.   

Abstract

Centrosome abnormalities occur frequently in various tumors and can cause chromosomal instability and eventually promote cancer development. We investigated the chromosome aberrations associated with centrosome abnormalities in 30 cases of breast cancer, combining immunohistochemical staining and comparative genomic hybridization. Except for some common chromosome alterations (including gains of 1q, 8q, 17q, 20q, and Xq and losses of 8p, 11q, 13q, 14q, 16q, 17p, 22q, and Xp) that have also been seen more frequently in other studies, we discovered some new changes that have rarely been reported, including gains at 2p, 5p, 10p, 15q, 16p, 18q, 21q, and 22q and losses at 6p, 8p23, 11p13-pter, 13q34, and 14q32-qter. We also identified some changes (such as gains of 17q, 20q, and Xq and losses of 17p, 13q, and 14q) harboring candidate genes. We also explored the expression of centrosome protein in different molecular subtypes of breast cancer. Our findings provide a new way to explore the molecular mechanisms of breast tumorigenesis and accordingly potential new targets for therapy for this disease.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21531002     DOI: 10.1016/j.humpath.2010.12.027

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  5 in total

1.  BUB1 immunolocalization in breast carcinoma: its nuclear localization as a potent prognostic factor of the patients.

Authors:  Kiyoshi Takagi; Yasuhiro Miki; Yukiko Shibahara; Yasuhiro Nakamura; Akiko Ebata; Mika Watanabe; Takanori Ishida; Hironobu Sasano; Takashi Suzuki
Journal:  Horm Cancer       Date:  2013-01-04       Impact factor: 3.869

2.  Identification and pathway analysis of microRNAs with no previous involvement in breast cancer.

Authors:  Sandra Romero-Cordoba; Sergio Rodriguez-Cuevas; Rosa Rebollar-Vega; Valeria Quintanar-Jurado; Antonio Maffuz-Aziz; Gerardo Jimenez-Sanchez; Veronica Bautista-Piña; Rocio Arellano-Llamas; Alfredo Hidalgo-Miranda
Journal:  PLoS One       Date:  2012-03-16       Impact factor: 3.240

3.  Human hyaluronic acid synthase-1 promotes malignant transformation via epithelial-to-mesenchymal transition, micronucleation and centrosome abnormalities.

Authors:  Nguyet Nguyen; Awanit Kumar; Simi Chacko; Rodney J Ouellette; Anirban Ghosh
Journal:  Cell Commun Signal       Date:  2017-11-14       Impact factor: 5.712

4.  Cdk4 and nek2 signal binucleation and centrosome amplification in a her2+ breast cancer model.

Authors:  Mary Kathryn Harrison Pitner; Harold I Saavedra
Journal:  PLoS One       Date:  2013-06-11       Impact factor: 3.240

5.  Genotype and Haplotype Analyses of TP53 Gene in Breast Cancer Patients: Association with Risk and Clinical Outcomes.

Authors:  Veronika Vymetalkova; Pavel Soucek; Tereza Kunicka; Katerina Jiraskova; Veronika Brynychova; Barbara Pardini; Vendula Novosadova; Zdena Polivkova; Katerina Kubackova; Renata Kozevnikovova; Miloslav Ambrus; Ludmila Vodickova; Alessio Naccarati; Pavel Vodicka
Journal:  PLoS One       Date:  2015-07-30       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.